Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2006 Mar;77(3):285-7.
doi: 10.1136/jnnp.2005.077495.

PPARs: a new target for neuroprotection

R Bordet, P Gelé, P Duriez, J-C Fruchart
Editorial

PPARs: a new target for neuroprotection

R Bordet et al. J Neurol Neurosurg Psychiatry. 2006 Mar.

Abstract

PPAR agonists are potential neuroprotective drugs

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

References

    1. Blanquart C, Barbier O, Fruchart J C.et al Peroxisome proliferator‐activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 200385267–273. - PubMed
    1. Bishop‐Bailey D. Peroxisome proliferator‐activated receptors in the cardiovascular system. Br J Pharmacol 2000129823–834. - PMC - PubMed
    1. Buchan K W, Hassall D G. PPAR agonists as direct modulators of the vessel wall in cardiovascular disease. Med Res Rev 200020350–366. - PubMed
    1. Berger J P, Akiyama T E, Meinke P T. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 200526244–251. - PubMed
    1. Luquet S, Lopez‐Soriano J, Holst D.et al Roles of peroxisome proliferators‐activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Biochimie 200486833–837. - PubMed

Publication types

MeSH terms

Substances